Covid-19 and Mucormycosis Superinfection: Prospective, Obsevational Study in a Single Center

BACKGROUND: Mucormycosis (MCR) has been increasingly described in patients with coronavirus disease 2019 (COVID-19), but the epidemiological factors, neurological presentation, and outcome of such patients are not well described. AIMS: To study the patient demographics, presenting symptoms and signs...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Shubham, Masheshwari, Dilip, Bhushan, Bharat, Sardana, Vijay, Jain, Raj Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350760/
https://www.ncbi.nlm.nih.gov/pubmed/35936631
http://dx.doi.org/10.4103/aian.aian_1097_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350760/
https://www.ncbi.nlm.nih.gov/pubmed/35936631
http://dx.doi.org/10.4103/aian.aian_1097_21

Ejemplares similares